Last Updated: June 24, 2026

ALCLOMETASONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Alclometasone

A generic version of ALCLOMETASONE was approved as alclometasone dipropionate by SUN PHARMA CANADA on July 29th, 2004.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for ALCLOMETASONE?
  • What are the global sales for ALCLOMETASONE?
  • What is Average Wholesale Price for ALCLOMETASONE?
Summary for ALCLOMETASONE
US Patents:0
Applicants:3
NDAs:6
Drug Prices: Drug price information for ALCLOMETASONE
DailyMed Link:ALCLOMETASONE at DailyMed

US Patents and Regulatory Information for ALCLOMETASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms ALCLOMETASONE DIPROPIONATE alclometasone dipropionate CREAM;TOPICAL 076973-001 Jul 12, 2005 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fougera Pharms ALCLOMETASONE DIPROPIONATE alclometasone dipropionate OINTMENT;TOPICAL 076884-001 Jul 18, 2005 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Glenmark Pharms Ltd ALCLOMETASONE DIPROPIONATE alclometasone dipropionate CREAM;TOPICAL 079061-001 Jun 23, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharma Canada ALCLOMETASONE DIPROPIONATE alclometasone dipropionate CREAM;TOPICAL 076587-001 Sep 15, 2005 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharma Canada ALCLOMETASONE DIPROPIONATE alclometasone dipropionate OINTMENT;TOPICAL 076730-001 Jul 29, 2004 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Glenmark Pharms Ltd ALCLOMETASONE DIPROPIONATE alclometasone dipropionate OINTMENT;TOPICAL 079227-001 Jul 30, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.